You just read:

Likely Delay for GSK/Janssen's Sirukumab Sets up Head to Head Battle Between Roche/Genentech's Actemra and Sanofi/Regeneron's Kevzara in the US Rheumatoid Arthritis Market

News provided by

Spherix Global Insights

Aug 09, 2017, 18:58 ET